Literature DB >> 17698216

Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction.

Jonathan W Weinsaft1, Matthew D Cham, Matthew Janik, James K Min, Claudia I Henschke, David F Yankelevitz, Richard B Devereux.   

Abstract

BACKGROUND: Left ventricular (LV) mass and ejection fraction are of diagnostic and therapeutic importance in patients with systolic dysfunction. Cardiac MRI (CMR) has been proposed as a standard for these indices. Prior studies have variably included papillary muscles and trabeculae in either intracavitary or myocardial volumes. Quantitative effects and clinical implications of this methodological difference in patients with systolic dysfunction are unknown.
METHODS: Fifty consecutive patients with known systolic dysfunction (EF<40%) underwent CMR. LV volumes were determined using previously established methods: Method 1 included papillary muscles and trabeculae in cavity volume, method 2 included these in myocardial volume. Both methods were used for each patient with tracings superimposed to isolate papillary/trabecular volume and insure consistency of other endocardial contours. Readers applied methods in random order blinded to clinical findings and results of the other method.
RESULTS: LV mass differed substantially by method (p<0.001) with absolute difference of 16.6%. Ejection fraction differed by 3 points (p<0.001) with absolute differences of > or =5 points in 16% of patients. Mean differences in LV mass and ejection fraction were produced by consistent methodological differences on a per-patient basis. Methodology used produced differences in patients meeting established criteria for LV hypertrophy (28% vs. 60%, p<0.001) and ICD implantation (64% vs. 48%, p<0.01).
CONCLUSIONS: LV mass and ejection fraction differ significantly between commonly employed CMR methods. Alternative inclusion of papillary muscles and trabeculae in either cavity or myocardial volumes produces significant differences in clinical and therapeutic indices that can affect management of patients with advanced systolic dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17698216     DOI: 10.1016/j.ijcard.2007.04.179

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  28 in total

1.  The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

Authors:  Mariëlle C van de Veerdonk; Sophie A Dusoswa; J Tim Marcus; Harm-Jan Bogaard; Onno Spruijt; Taco Kind; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-04       Impact factor: 2.357

2.  Automatic functional analysis of left ventricle in cardiac cine MRI.

Authors:  Ying-Li Lu; Kim A Connelly; Alexander J Dick; Graham A Wright; Perry E Radau
Journal:  Quant Imaging Med Surg       Date:  2013-08

3.  Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy.

Authors:  D H F Gommans; J Bakker; G E Cramer; F W A Verheugt; M A Brouwer; M J M Kofflard
Journal:  Neth Heart J       Date:  2016-05       Impact factor: 2.380

4.  Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function.

Authors:  Michael L Chuang; Philimon Gona; Gilion L T F Hautvast; Carol J Salton; Susan J Blease; Susan B Yeon; Marcel Breeuwer; Christopher J O'Donnell; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

5.  Improving the reproducibility of MR-derived left ventricular volume and function measurements with a semi-automatic threshold-based segmentation algorithm.

Authors:  Karolien Jaspers; Hendrik G Freling; Kees van Wijk; Elisabeth I Romijn; Marcel J W Greuter; Tineke P Willems
Journal:  Int J Cardiovasc Imaging       Date:  2012-09-29       Impact factor: 2.357

6.  Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging.

Authors:  Maria Angela Losi; Massimo Imbriaco; Grazia Canciello; Filomena Pacelli; Carlo Di Nardo; Raffaella Lombardi; Raffaele Izzo; Costantino Mancusi; Andrea Ponsiglione; Serena Dell'Aversana; Alberto Cuocolo; Giovanni de Simone; Bruno Trimarco; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2019-09-05       Impact factor: 4.132

7.  Left and right ventricular parameters corrected with threshold-based quantification method in a normal cohort analyzed by three independent observers with various training-degree.

Authors:  Ibolya Csecs; Csilla Czimbalmos; Ferenc Imre Suhai; Róbert Mikle; Arash Mirzahosseini; Zsófia Dohy; Andrea Szűcs; Anna Réka Kiss; Tamás Simor; Attila Tóth; Béla Merkely; Hajnalka Vágó
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-28       Impact factor: 2.357

8.  Improved approach to quantitative cardiac volumetrics using automatic thresholding and manual trimming: a cardiovascular MRI study.

Authors:  Geetha Rayarao; Robert W W Biederman; Ronald B Williams; June A Yamrozik; Richard Lombardi; Mark Doyle
Journal:  J Med Imaging (Bellingham)       Date:  2018-02-14

9.  Left ventricular stroke volume quantification by contrast echocardiography - comparison of linear and flow-based methods to cardiac magnetic resonance.

Authors:  Abiola O Dele-Michael; Kana Fujikura; Richard B Devereux; Fahmida Islam; Ingrid Hriljac; Sean R Wilson; Fay Lin; Jonathan W Weinsaft
Journal:  Echocardiography       Date:  2013-03-12       Impact factor: 1.724

10.  Impact of end-diastolic and end-systolic phase selection in the volumetric evaluation of cardiac MRI.

Authors:  Francisco Contijoch; Walter R T Witschey; Kelly Rogers; Joseph Gorman; Robert C Gorman; Victor Ferrari; Yuchi Han
Journal:  J Magn Reson Imaging       Date:  2015-09-02       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.